Intensive Care Medicine最新文献

筛选
英文 中文
Beyond classical boundaries: rethinking ICU access in acute leukemia 超越经典界限:重新思考急性白血病ICU准入
IF 38.9 1区 医学
Intensive Care Medicine Pub Date : 2026-09-22 DOI: 10.1007/s00134-026-08623-y
Guillaume Berton,Norbert Vey
{"title":"Beyond classical boundaries: rethinking ICU access in acute leukemia","authors":"Guillaume Berton,Norbert Vey","doi":"10.1007/s00134-026-08623-y","DOIUrl":"https://doi.org/10.1007/s00134-026-08623-y","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"1 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149020709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multicenter randomized, double-blinded placebo-controlled phase 2 trial to evaluate safety and efficacy of ilofotase alfa in patients at risk for kidney injury following open heart surgery. 一项多中心随机、双盲、安慰剂对照的2期试验,旨在评估ilofotase在心脏直视手术后肾损伤风险患者中的安全性和有效性。
IF 22 1区 医学
Intensive Care Medicine Pub Date : 2026-09-21 DOI: 10.1007/s00134-026-08596-y
Louis Mourisse, Marlies Ostermann, Steven Thiessen, Alexander Dumoulin, Alexander P J Vlaar, Eric Hoste, Selim Mosbahi, Antoine Schneider, Alexander Zarbock, Johannes Boehm, Peter Rosenberger, Matthias Thielmann, Eric Dubois, Jonah Powell-Tuck, Kamran Baig, Wencke Renette, Ingrid Meex, Margreet Klop-Rhiel, Krijna Opschoor, Wim Vandenberghe, Matthias Siepe, Christian Strauss, Felix Wirth, Matthias Winkel, Liesbeth Hof, Maarten Kraan, Juliane Bernholz, Peter Pickkers
{"title":"A multicenter randomized, double-blinded placebo-controlled phase 2 trial to evaluate safety and efficacy of ilofotase alfa in patients at risk for kidney injury following open heart surgery.","authors":"Louis Mourisse, Marlies Ostermann, Steven Thiessen, Alexander Dumoulin, Alexander P J Vlaar, Eric Hoste, Selim Mosbahi, Antoine Schneider, Alexander Zarbock, Johannes Boehm, Peter Rosenberger, Matthias Thielmann, Eric Dubois, Jonah Powell-Tuck, Kamran Baig, Wencke Renette, Ingrid Meex, Margreet Klop-Rhiel, Krijna Opschoor, Wim Vandenberghe, Matthias Siepe, Christian Strauss, Felix Wirth, Matthias Winkel, Liesbeth Hof, Maarten Kraan, Juliane Bernholz, Peter Pickkers","doi":"10.1007/s00134-026-08596-y","DOIUrl":"https://doi.org/10.1007/s00134-026-08596-y","url":null,"abstract":"<p><strong>Introduction: </strong>Acute impairment of kidney function after cardiac surgery is common and associated with an increased morbidity and mortality. Ilofotase alfa has demonstrated potential to attenuate renal injury through its immunomodulatory effects. We evaluated the safety and efficacy of ilofotase alfa in preventing renal functional impairment in cardiac surgery patients.</p><p><strong>Methods: </strong>This phase 2, multi-center, randomized, double-blinded, placebo-controlled trial employing a two-arm, parallel-group design randomized adult patients at a high risk of renal functional impairment after on-pump cardiac surgery. Patients with a pre-existent estimated glomerular filtration rate of 25-65 ml/min/1.73m<sup>2</sup> scheduled to undergo complex cardiac surgery were eligible. Patients received two intravenous doses (128 mg) of ilofotase alfa or placebo perioperatively. The primary endpoint was the ratio between the highest serum creatinine levels within five days postoperative relative to the pre-operative level (sCrRatio). The secondary endpoint was major adverse kidney events up to day 60 (MAKE60).</p><p><strong>Results: </strong>In total, 244 patients were randomized of whom 204 received two doses and were included in the trial analysis: 109 patients were treated with ilofotase alfa and 95 received placebo. The mean±SD sCrRatio in the ilofotase alfa group was 1.21±0.42, compared to 1.27±0.50 for placebo (p=0.31). MAKE60 incidence was 15.9% in the ilofotase alfa group and 15.4% in the placebo group (p=0.87). No safety concerns were raised.</p><p><strong>Conclusion: </strong>Administration of ilofotase alfa did not attenuate short- and longer-term renal function loss in patients at a high risk of renal functional impairment after on-pump cardiac surgery. No safety concerns of ilofotase alfa emerged.</p><p><strong>Trial registration: </strong>EUCT Number: 2023-505859-45 US IND Number: 117 605 ClinicalTrials.gov ID: NCT06168799.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":""},"PeriodicalIF":22.0,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149016726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rehabilitation and the post-intensive care syndrome across the recovery continuum: a narrative review. 康复和重症监护后综合症跨越康复连续体:叙述性回顾。
IF 22 1区 医学
Intensive Care Medicine Pub Date : 2026-09-09 DOI: 10.1007/s00134-026-08600-5
Stefan J Schaller, Teresa Cardoso, Sabrina Eggmann, Martina Hermann, Cheryl E Hickmann, Rahel Naef, Margo van Mol, Simone Piva, Emilio Rodriguez-Ruiz, Mahan Sadjadi, Akos Tiboldi, Greet Van den Berghe, Marion Wiegele, David McWilliams, Björn Weiss
{"title":"Rehabilitation and the post-intensive care syndrome across the recovery continuum: a narrative review.","authors":"Stefan J Schaller, Teresa Cardoso, Sabrina Eggmann, Martina Hermann, Cheryl E Hickmann, Rahel Naef, Margo van Mol, Simone Piva, Emilio Rodriguez-Ruiz, Mahan Sadjadi, Akos Tiboldi, Greet Van den Berghe, Marion Wiegele, David McWilliams, Björn Weiss","doi":"10.1007/s00134-026-08600-5","DOIUrl":"10.1007/s00134-026-08600-5","url":null,"abstract":"<p><strong>Purpose: </strong>Improved survival from critical illness has produced a growing population of intensive care unit (ICU) survivors with new or worsened physical, cognitive, and mental-health impairment, defined as post-intensive care syndrome (PICS), and frequent distress among families/caregivers (PICS-family, PICS-F). This narrative review synthesises the evidence in adults treated in high-resource settings.</p><p><strong>Methods: </strong>Rather than a formal guideline process, we used a structured descriptive approach: for each recommendation, we identified the predominant study design, assessed the consistency of findings, summarised uncertainties, and assigned an evidence-strength label (high, moderate, low, or insufficient).</p><p><strong>Results: </strong>We summarise the definition of PICS and its overlap with related constructs (post-sepsis morbidity, chronic critical illness, post-COVID conditions, and frailty); the mechanisms linking acute injury to persistent disability, including skeletal-muscle pathobiology, neuroinflammation, mitochondrial and neuroendocrine dysfunction, and epigenetic change; and the instruments assessing the three PICS core domains (recommending a two-step assessment approach), as well as quality of life, across the care continuum. We describe preventive and rehabilitative interventions from the ICU (e.g., the ABCDEF bundle that includes light/no sedation, delirium prevention, early mobilisation and family participation) through the ward to the post-hospital phase, the heterogeneous organisation of post-ICU recovery services, PICS-F, the educational and cultural change needed, and the health-system and policy context. PICS-F affects 20-60% of relatives; nurse-led family interventions seem promising.</p><p><strong>Conclusion: </strong>The evidence base remains limited and heterogeneous, preventing firm recommendations. Research priorities include harmonised outcome measurement, phenotyping of recovery trajectories, the optimal dose and timing of rehabilitation, and rigorous comparison of follow-up models.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":""},"PeriodicalIF":22.0,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148919618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal trends in critical care burden and outcomes of Andes virus-associated hantavirus cardiopulmonary syndrome: a national Chilean cohort. 安第斯病毒相关汉坦病毒心肺综合征重症监护负担和结局的时间趋势:智利国家队列
IF 22 1区 医学
Intensive Care Medicine Pub Date : 2026-09-02 DOI: 10.1007/s00134-026-08599-9
Gabriela Meza-Fuentes, Iris Delgado, Pablo A Vial, Alex Godoy-Faúndez, Diego Rivera, Yanara Bernal, Jerónimo Graf, René López
{"title":"Temporal trends in critical care burden and outcomes of Andes virus-associated hantavirus cardiopulmonary syndrome: a national Chilean cohort.","authors":"Gabriela Meza-Fuentes, Iris Delgado, Pablo A Vial, Alex Godoy-Faúndez, Diego Rivera, Yanara Bernal, Jerónimo Graf, René López","doi":"10.1007/s00134-026-08599-9","DOIUrl":"https://doi.org/10.1007/s00134-026-08599-9","url":null,"abstract":"<p><strong>Purpose: </strong>Andes virus causes hantavirus cardiopulmonary syndrome (HCPS), a severe disease found in central and southern parts of Chile and Argentina. Recently a case-outbreak of HCPS was reported on a cruise ship, therefore contemporary data on organ support and outcomes is required. The objective of this study was to assess organ support use and patient outcomes in patients admitted with HCPS.</p><p><strong>Methods: </strong>We used the Diagnosis-Related Groups (DGR) database to analyse patients admitted in 31 Chilean hospitals between January 1, 2019, and December 31, 2024. They were stratified by the maximal respiratory support received: no respiratory support, non-invasive ventilation (NIV), invasive mechanical ventilation (MV) or extracorporeal membrane oxygenation (ECMO). Hospital length of stay (LOS) and in-hospital mortality were the main outcomes assessed. In-hospital mortality was further analysed by pre-COVID-19 pandemic, pandemic, and post-pandemic periods.</p><p><strong>Results: </strong>A total of 215 patients with HCPS were identified, of whom 69.3% were males and 87% were adults. Of 148 patients who required respiratory support, 14.2% received NIV, 36.5% received MV and 49.3% required ECMO. Hospital LOS was 8 [3-15] days and in-hospital mortality was 20.5%. Case fatality rates were 29.6% for patients receiving MV and 32.9% for those receiving ECMO. The pandemic period was independently associated with higher in-hospital mortality (aOR 2.73 [1.06-7.63]; p = 0.045).</p><p><strong>Conclusion: </strong>HCPS caused by Andes virus remains associated with high in-hospital mortality and substantial amounts of respiratory support, particularly MV and ECMO. Moreover, the COVID-19 pandemic was associated with a significant increase in HCPS mortality.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":""},"PeriodicalIF":22.0,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148880207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative ARDS: beyond definitions toward etiology-driven care. 围手术期急性呼吸窘迫综合征:超越病因驱动护理的定义。
IF 22 1区 医学
Intensive Care Medicine Pub Date : 2026-09-01 Epub Date: 2026-05-07 DOI: 10.1007/s00134-026-08465-8
Stefano Romagnoli, Lorenzo Ball, Samir Jaber
{"title":"Perioperative ARDS: beyond definitions toward etiology-driven care.","authors":"Stefano Romagnoli, Lorenzo Ball, Samir Jaber","doi":"10.1007/s00134-026-08465-8","DOIUrl":"10.1007/s00134-026-08465-8","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":"2023-2025"},"PeriodicalIF":22.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147837534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imaging in ARDS: physiology-guided decisions in the AI era. 急性呼吸窘迫综合征的影像学:人工智能时代的生理引导决策。
IF 22 1区 医学
Intensive Care Medicine Pub Date : 2026-09-01 Epub Date: 2026-06-03 DOI: 10.1007/s00134-026-08503-5
Lorenzo Ball, Luigi Camporota, Jean-Michel Constantin
{"title":"Imaging in ARDS: physiology-guided decisions in the AI era.","authors":"Lorenzo Ball, Luigi Camporota, Jean-Michel Constantin","doi":"10.1007/s00134-026-08503-5","DOIUrl":"10.1007/s00134-026-08503-5","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":"2003-2005"},"PeriodicalIF":22.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148149810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ARDS management in trauma patients. 创伤患者急性呼吸窘迫综合征的处理。
IF 22 1区 医学
Intensive Care Medicine Pub Date : 2026-09-01 Epub Date: 2026-08-26 DOI: 10.1007/s00134-026-08581-5
Sergio Lassola, Francesco Cipulli, Eleonora Balzani, Sandra Magnoni, Marco Mastandrea, Riccardo Giovannetti, Simon Rauch, Xavier Monnet, Giacomo Bellani
{"title":"ARDS management in trauma patients.","authors":"Sergio Lassola, Francesco Cipulli, Eleonora Balzani, Sandra Magnoni, Marco Mastandrea, Riccardo Giovannetti, Simon Rauch, Xavier Monnet, Giacomo Bellani","doi":"10.1007/s00134-026-08581-5","DOIUrl":"10.1007/s00134-026-08581-5","url":null,"abstract":"<p><p>Acute respiratory distress syndrome (ARDS) is a frequent and severe complication in trauma patients, arising from a complex interplay between direct tissue injury, systemic inflammation, and resuscitation-related factors. Although trauma accounts for a minority of ARDS cases overall, its incidence remains high in patients with severe thoracic injury. The pathophysiology is best described by a \"multi-hit\" model, in which the initial traumatic insult is followed by a dysregulated inflammatory response and additional secondary insults, including transfusion, infection, or fat embolism, ultimately leading to alveolar-capillary barrier disruption and respiratory failure. Early identification of patients at risk is crucial and relies on clinical severity scores and multimodal imaging. Thoracic imaging, including chest X-ray, lung ultrasound, and computed tomography, plays a central role in diagnosis, monitoring, and risk stratification. Management is largely supportive and based on lung-protective ventilation strategies, with careful integration of non-invasive respiratory support in selected patients. Pain control, hemodynamic optimization, and timely surgical interventions are key components of care, as they directly influence respiratory mechanics and may prevent progression to ARDS. Special clinical scenarios, including traumatic brain injury and hypothermia, require individualized approaches due to complex brain-lung and systemic interactions. Overall, a multidisciplinary, physiology-driven strategy is essential to optimize outcomes in trauma-related ARDS.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":"1943-1957"},"PeriodicalIF":22.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13562153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148828009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An unusual ARDS mimicker. 一个不寻常的ARDS模仿者。
IF 22 1区 医学
Intensive Care Medicine Pub Date : 2026-09-01 Epub Date: 2026-06-09 DOI: 10.1007/s00134-026-08507-1
Stéphane Bourlet, Salomé Smadja, Shanta Valainathan, Damien Contou
{"title":"An unusual ARDS mimicker.","authors":"Stéphane Bourlet, Salomé Smadja, Shanta Valainathan, Damien Contou","doi":"10.1007/s00134-026-08507-1","DOIUrl":"10.1007/s00134-026-08507-1","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":"2035-2037"},"PeriodicalIF":22.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148204809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prone positioning in ARDS. ARDS俯卧位。
IF 22 1区 医学
Intensive Care Medicine Pub Date : 2026-09-01 Epub Date: 2026-07-20 DOI: 10.1007/s00134-026-08543-x
Stephan Ehrmann, Jie Li, Ling Liu, Claude Guérin
{"title":"Prone positioning in ARDS.","authors":"Stephan Ehrmann, Jie Li, Ling Liu, Claude Guérin","doi":"10.1007/s00134-026-08543-x","DOIUrl":"10.1007/s00134-026-08543-x","url":null,"abstract":"<p><p>Over the past five decades, prone positioning has evolved from single case reports to an evidence-based intervention. Initially used as a rescue therapy, it is now recognized as an integral component of lung-protective mechanical ventilation strategies, applied early in intubated patients with acute respiratory distress syndrome (ARDS) with a PaO<sub>2</sub>/F<sub>I</sub>O<sub>2</sub> ratio < 150 mmHg. The COVID-19 pandemic further expanded its use to non-intubated patients, the so-called awake prone position (APP), with promising results. APP requires confirmation in non-COVID patients and in a more routine ICU practice. Improved oxygenation is a consistent and well-recognized effect of prone positioning in both intubated and non-intubated patients with ARDS. Beyond its effects on gas exchange, prone positioning mitigates ventilator-induced lung injury by reducing lung stress and strain and may also confer favorable hemodynamic effects. This article reviews the physiologic rationale for prone positioning, evidence from randomized controlled trials, current guideline recommendations, practical aspects of implementation, and ongoing questions in both intubated and non-intubated patients.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":"1881-1894"},"PeriodicalIF":22.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13562319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148520154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute respiratory distress syndrome in patients with obesity. 肥胖患者的急性呼吸窘迫综合征。
IF 22 1区 医学
Intensive Care Medicine Pub Date : 2026-09-01 Epub Date: 2026-05-27 DOI: 10.1007/s00134-026-08488-1
Audrey De Jong, Lorenzo Berra, Gonzalo Hernández
{"title":"Acute respiratory distress syndrome in patients with obesity.","authors":"Audrey De Jong, Lorenzo Berra, Gonzalo Hernández","doi":"10.1007/s00134-026-08488-1","DOIUrl":"10.1007/s00134-026-08488-1","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":"1989-1991"},"PeriodicalIF":22.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148029923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书